Stem is trading 5.25% up at $4.71 on September 28, extending Friday’s sharp rebound, with no clear new company catalyst identified.
- No new company announcement or analyst action dated September 28 clearly explains the additional gain.
- UBS upgraded Stem to Buy on September 25 with a $7 price target; this is recent background, not an established direct catalyst.
- The broader market is lower, so Stem’s move is not tracking the day’s index direction.